Financial Results - Xenetic Biosciences, Inc. reported financial results for the year ended December 31, 2023, with a focus on corporate updates[6] - The press release detailing the financial results is included as Exhibit 99.1, which is referenced in the report[7] Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[5] Forward-Looking Statements - Forward-looking statements in the report are subject to risks and uncertainties, including market conditions and regulatory processes[8] - The company does not undertake any obligation to update forward-looking statements except as required by law[8] Report Signing - The report was signed by Chief Financial Officer James Parslow on March 22, 2024[13]
Xenetic Biosciences(XBIO) - 2023 Q4 - Annual Results